Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences Ltd Share Price Today: Live Updates & Key Insights

Get insights on Solara Active Pharma Sciences Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Solara Active Pharma Sciences Ltd Share Price Chart

stocks
To Invest in Solara Active Pharma Sciences Ltd
stocks

Solara Active Pharma Sciences Ltd Fundamentals

Traded Volume: 59,007

Market Cap(Cr): 1,981

Avg Traded Price 550.64

1 Year return -28.07%

Upper Circuit 565.9

Lower Circuit 544.4

P/E TTM 380.00

P/B Ratio 1.00

Traded Value(Cr) 323.18

EPS TTM 1.441

Book value 1.441

Dividend 0.00%

Solara Active Pharma Sciences Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Solara Active Pharma Sciences Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Solara Active Pharma Sciences Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -4.02%

1M -7.41%

3M -13.08%

1Y -28.07%

YTD -19.72%

Solara Active Pharma Sciences Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Solara Active Pharma Sciences Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 64062.00

Day Before Yesterday 88414.00

1W Avg 74088.20

1M Avg 1.60L

3M Avg 1.39L

Solara Active Pharma Sciences Ltd Technical Details

Solara Active Pharma Sciences Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 539

Support 2 531

Support 3 518

Pivot Point : 553

Resistance 1 561

Resistance 2 574

Resistance 3 583

Solara Active Pharma Sciences Ltd Corporate Actions

Solara Active Pharma Sciences Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Solara Active Pharma Sciences Ltd’s capital allocation strategies.

All

Ex-Date 15-May-2024 Type R Description /share@1:3% Record Date 15-May-2024 Ratio 1:3

Ex-Date 18-Aug-2021 Type D Description 3.00/share@30.00% Record Date 20-Aug-2021 Ratio 30.00

Ex-Date 19-Nov-2020 Type D Description 4.00/share@40.00% Record Date 20-Nov-2020 Ratio 40.00

Ex-Date 28-Jul-2020 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00

Ex-Date 06-Aug-2019 Type D Description 5.00/share@50.00% Record Date - Ratio 50.00

Dividends

Announcement Date 18-Aug-2021 Ex Dividend Date 18-Aug-2021 Dividend(%) 30

Announcement Date 19-Nov-2020 Ex Dividend Date 19-Nov-2020 Dividend(%) 40

Announcement Date 28-Jul-2020 Ex Dividend Date 28-Jul-2020 Dividend(%) 20

Announcement Date 06-Aug-2019 Ex Dividend Date 06-Aug-2019 Dividend(%) 50

Bonus

No Bonus has been declared by SOLARA

Splits

No Split has been declared by SOLARA

Others

Ex-Rights Date 15-May-2024 Premium(Rs.) 365.00 Ratio 1:3

Solara Active Pharma Sciences Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Solara Active Pharma Sciences Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Solara Active Pharma Sciences Ltd's relative performance and valuation against major competitors.

Solara Active Pharma Sciences Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Solara Active Pharma Sciences Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 212.80 Mar 2024 110.95 Mar 2023 156.17 Mar 2022 -241.77 Mar 2021 154.44

PARTICULARS Investing Activities Mar 2025 -36.83 Mar 2024 -4.66 Mar 2023 -81.13 Mar 2022 -243.08 Mar 2021 -105.25

PARTICULARS Financing Activities Mar 2025 -180.48 Mar 2024 -106.52 Mar 2023 -112.76 Mar 2022 333.59 Mar 2021 92.50

PARTICULARS Net Cash Flow Mar 2025 -4.51 Mar 2024 -0.23 Mar 2023 -37.72 Mar 2022 -151.26 Mar 2021 141.69

Solara Active Pharma Sciences Ltd Shareholding Pattern

This shows the ownership breakdown of Solara Active Pharma Sciences Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 42.01%

Public 41.71%

Other Institutions 1.51%

FII 13.58%

Mutual Funds 1.18%

About Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets. The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others. These drugs primarily deal with anthelmintic, anti-malarias, beta blockers, muscle relaxants, novel oral anticoagulants, anti-infective and other niche segments.The Company's manufacturing facilities enjoy regulatory approvals from the United States Food and Drug Administration (USFDA); European Directorate for the Quality of Medicines (EDQM); Korea Food & Drug Administration (KFDA) - South Korea; Euro Zone - Good Manufacturing Practice (EUGMP) - Danish, World Health Organization (WHO) - Geneva; Medicines and Healthcare products Regulatory Agency (MHRA); Federal Commission for the Protection against Sanitary Risk (Cofepris) - Mexico; Therapeutic Goods Administration (TGA) - Australia; Pharmaceuticals and Medical Devices Agency (PMDA) - Japan.The Company acquired 100% of the equity shares of Strides Chemicals Private Limited and made it the wholly owned subsidiary of the Company effective from September 1, 2018. During the year 2018-19, the Company's wholly owned subsidiary Strides Chemicals Private Limited amalgamated with the Company on December 20, 2019 and the merger was given effect in February, 2020. The Company's new Greenfield plant situated at SEZ unit, Plot No.:3B,3C,3D, Part 2 and 2A-1, APIIC APSEZ, Atchutapuram Village, Rambilli Mandal, Visakhapatnam - 531011, Andhra Pradesh, commenced commercial production in 2021.The Company acquired 487000 additional stake in Sequent Penems Private Limited, subsidiary company and subsequently Sequent Pharma became the wholly owned subsidiary of Company effective from April 27, 2021. In 2024, the Company sold its entire shareholding in Sequent Penems Private Limited to Symbio Generrics India Private Limited and Sequent Penems Private Limited ceased to be a subsidiary of the Company with effect from April 25, 2024.The wholly owned entity, Synthix Global Pharma Solutions Limited has got incorporated on April 29, 2025. .

Chairman & Independent Directo

RAJAGOPALAN RAMAKRISHNAN

Registered office 201 Devavrata Sector 17 Vashi, Navi Mumbai, Mumbai, Maharashtra, 400703

FAX :91-22-27892924

Background

Incorporation Year 2017

Face Value ₹10.00

Market Lot 1

Solara Active Pharma Sciences Ltd Latest News

news-by-symbol

VIEW MORE NEWS

FAQs on Solara Active Pharma Sciences Ltd

How to buy Solara Active Pharma Sciences Ltd shares on NSE?

To buy Solara Active Pharma Sciences Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.

What is the Solara Active Pharma Sciences Ltd share price today?

The Solara Active Pharma Sciences Ltd share price on NSE is ₹547.70 today.

What is the market cap of Solara Active Pharma Sciences Ltd on NSE?

The company has a market capitalization of ₹1981.10.

What is the PE & PB ratio of Solara Active Pharma Sciences Ltd?

PE is 380 and PB is 1.

What is the 52 Week High and Low of Solara Active Pharma Sciences Ltd shares?

Solara Active Pharma Sciences Ltd stock price high: ₹882.80 Solara Active Pharma Sciences Ltd stock price low: ₹442.80.

How do I invest in Solara Active Pharma shares?

To invest in Solara Active Pharma shares through Motilal Oswal, open a trading account, complete KYC formalities, transfer funds, log in to the trading platform, search for the shares, buy them, and wait for them to be credited to your demat account.

What will be the future of Solara Active Pharma shares?

While Solara’s stock has shed value in the past year, it has now returned to profitability. Additionally, the Founder and Non-Executive Director Arun Pillai bought shares well above current rates to infuse optimism amongst potential investors. That is an indication of confidence in upward movement of the stock.

What are the factors that influence the share price of Solara Active Pharma?

The financial performance of the company, including revenue growth, profitability, and earnings, can affect its share price. Furthermore, macroeconomic factors such as interest rates, inflation, investor perception of the Indian market, and industry trends can affect Solara’s share price.

What is the long-term growth potential of Solara Active Pharma?

Solara Active Pharma shows great potential for growth after amalgamating Aurore Life Science, Empyrean Lifesciences, and Hydra Active Pharma into Solara. Additionally, the WHO recently completed an inspection of the Cuddalore facility, which is expected to boost the share price in the long term.

What is the upcoming dividend for Solara Active Pharma shares?

Solara paid its last dividend of Rs. 3 per share on May 6th, 2021. Despite the company turning a profit in December 2022, there is no news of an upcoming dividend.

How often are dividends paid on Solara Active Pharma shares?

Solara Active Pharma has declared dividend four times in the last five years.